Showing results (51-60 of 3,346) with videos related to

Sort By:
Pageof 335
Pharmacoeconomics|July 13, 2022
Carers' Health-Related Quality of Life in Global Health Technology Assessment: Guidance, Case Studies and RecommendationsBecky Pennington, Jack Eaton, Anthony J Hatswell, et al.
Pharmacoeconomics|July 26, 2022
Budget Impact Analysis of Vibegron for the Treatment of Overactive Bladder in the USAJing Voon Chen, James C Gahn, Jeffrey Nesheim, et al.
Pharmacoeconomics|March 3, 2022
Assessments of the Value of New Interventions Should Include Health Equity ImpactJeroen P Jansen, Thomas A Trikalinos, Kathryn A Phillips
Pharmacoeconomics|November 22, 2023
Surrogacy and the Valuation of ATMPs: Taking Our Place in the Evidence Generation/Assessment ContinuumDaniel Gladwell, Oriana Ciani, Adam Parnaby, et al.
Pharmacoeconomics|November 22, 2023
Using Real-World Data to Inform Value-Based Contracts for Cell and Gene Therapies in MedicaidAntal Zemplenyi, Jim Leonard, Michael J DiStefano, et al.
Pharmacoeconomics|November 10, 2023
Estimating Costs Associated with Disease Model States Using Generalized Linear Models: A TutorialJunwen Zhou, Claire Williams, Mi Jun Keng, et al.
Pharmacoeconomics|August 22, 2023
Lipid-Lowering Strategies for Primary Prevention of Coronary Heart Disease in the UK: A Cost-Effectiveness AnalysisJedidiah I Morton, Clara Marquina, Melanie Lloyd, et al.
Pharmacoeconomics|September 26, 2023
Economic Evaluations Comparing Deep Brain Stimulation to Best Medical Therapy for Movement Disorders: A Meta-AnalysisMelissa Lannon, Taylor Duda, Alexander Mastrolonardo, et al.
Pageof 335